Compile Data Set for Download or QSAR
Report error Found 709 Enz. Inhib. hit(s) with Target = 'Serine/threonine-protein kinase PAK 4'
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101479(US8530652, 6 | US8530652, 50 | US8524710, 56)
Affinity DataKi:  2.80nM EC50:  0.940nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM2579(CHEMBL388978 | Staurosporine, 8 | Staurosporin, 4 ...)
Affinity DataIC50: 1nMAssay Description:Inhibition of PAK4 (unknown origin) by HTRF assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2021
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50389123(CHEMBL2064631)
Affinity DataEC50:  1nMAssay Description:Inhibition of PAK4-mediated GEF-H1 phosphorylation at Ser810 by cell based assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 1.30nMAssay Description:Inhibition of human PAK4 expressed in TR-293-KDG cells assessed as inhibition of GEFH1 phosphorylation at S180 using GEFH1 as substrate incubated for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101618(US8530652, 114)
Affinity DataIC50: 1.30nMAssay Description:Inhibition of PAK4 Kinase domain (291 to 591 residues) (unknown origin) transfected in TR-293-KDG cells using GEFH1 as substrate assessed as inhibiti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101546(US8530652, 73 | US8530652, 125 | US8530494, 211)
Affinity DataKi:  1.60nM EC50: <3.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101543(US8530652, 122 | US8530652, 70 | US8530494, 206)
Affinity DataKi:  8.80nM EC50:  1.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM2579(CHEMBL388978 | Staurosporine, 8 | Staurosporin, 4 ...)
Affinity DataIC50: 1.90nMAssay Description:Inhibition of recombinant human N-terminal GST-fused PAK4 (1 to 591 residues) expressed in baculovirus expression system using S2 as substrate measur...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2019
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101542(US8530652, 69 | US8530652, 121 | US8530494, 207)
Affinity DataKi:  1.90nM EC50:  3nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50097131(CHEMBL3580667)
Affinity DataKi:  2nMAssay Description:Inhibition of human PAK4More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/21/2016
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101532(US8530652, 59 | US8530652, 110 | US8530494, 201)
Affinity DataKi:  170nM EC50:  2.40nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101530(US8530652, 57 | US8530494, 29 | US8530494, 7)
Affinity DataKi:  14nM EC50:  2.5nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM130909(US8822500, Stauro- sporine | US9920060, Staurospor...)
Affinity DataIC50: 2.60nMAssay Description:Inhibition of human PAK4 using RRRLSFAEPG as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKd:  2.70nMAssay Description:Binding affinity to human PAK4 (300 to 591 residues) assessed as dissociation constant by isothermal calorimetric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKd:  2.70nMAssay Description:Binding affinity to PAK4 catalytic domain (unknown origin) assessed as equilibrium dissociation constant at 50 uM by ITC analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50600087(CHEMBL5180027)
Affinity DataIC50: 2.70nMAssay Description:Inhibition of human PAK4 assessed as enzymatic activity incubated for 20 mins by filter binding methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/23/2023
Entry Details
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKd:  2.70nMAssay Description:Binding affinity to N-terminal his6-tagged human recombinant PAK4 (300 to 591 residues) assessed as dissociation constant by SPR analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50389112(CHEMBL2064556)
Affinity DataKi:  2.80nMAssay Description:Inhibition of PAK4More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101537(US8530652, 115 | US8530652, 64 | US8530494, 204)
Affinity DataKi:  3nM EC50: <3.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50600091(CHEMBL5191406)
Affinity DataKi:  3.30nMAssay Description:Inhibition of human PAK4 assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/23/2023
Entry Details
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50448771(CHEMBL3128042)
Affinity DataKi:  3.30nMAssay Description:Inhibition of human recombinant PAK4 assessed as inhibition constant incubated for 10 mins by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50448771(CHEMBL3128042)
Affinity DataKi:  3.30nMAssay Description:Inhibition of human recombinant PAK4 using KKRNRRLSVA as substrate assessed as inhibition constant preincubated with compound for 10 mins followed by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50448771(CHEMBL3128042)
Affinity DataKi:  3.30nMAssay Description:Binding affinity to N-terminal GST-tagged recombinant human PAK4 kinase domain expressed in Escherichia coli using KKRNRRLSVA as substrate preincubat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/26/2014
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM4838(US8524710, 83 | US8530494, 13 | US8530652, 52)
Affinity DataKi:  3.5nM EC50:  19nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM4838(US8524710, 83 | US8530494, 13 | US8530652, 52)
Affinity DataKi:  3.5nM EC50:  19nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101547(US8530652, 74 | US8530652, 126 | US8530494, 212)
Affinity DataKi:  3.60nM EC50: <3.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101533(US8530652, 111 | US8530652, 60 | US8530494, 103)
Affinity DataKi:  40nM EC50: <3.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101549(US8530652, 128 | US8530652, 76 | US8530494, 109)
Affinity DataKi:  8.30nM EC50: <3.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101548(US8530652, 75 | US8530652, 127 | US8530494, 108)
Affinity DataKi:  5.20nM EC50: <3.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101536(US8530652, 63 | CHEMBL3128043 | US8530494, 203)
Affinity DataKi:  20nM EC50: <3.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101552(US8530652, 79 | US8530652, 131 | US8530494, 214)
Affinity DataKi:  39nM EC50: >3.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101539(US8530652, 66 | US8530652, 117 | US8530494, 106)
Affinity DataKi:  170nM EC50: <3.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50097144(CHEMBL3580963)
Affinity DataKi:  4nMAssay Description:Inhibition of human recombinant PAK4 kinase domain using coumarin/fluorescein-labeled FRET peptide as substrate assessed as substrate phosphorylation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/21/2016
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Mus musculus)
Genentech

Curated by ChEMBL
LigandPNGBDBM50389121(CHEMBL2064628)
Affinity DataEC50:  4nMAssay Description:Inhibition of PAK4 in mouse NIH3T3 cells assessed as reduction in phosphorylated GEF-H1 accumulation incubated for 30 mins by immunoblotting analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50389121(CHEMBL2064628)
Affinity DataEC50:  4nMAssay Description:Inhibition of PAK4-mediated GEF-H1 phosphorylation at Ser810 by cell based assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50097131(CHEMBL3580667)
Affinity DataKi:  4nMAssay Description:Inhibition of PAK4 (unknown origin) assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101545(US8530652, 72 | US8530652, 124 | US8530494, 107)
Affinity DataKi:  16nM EC50:  4.40nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101618(US8530652, 114)
Affinity DataKd:  4.5nMAssay Description:Binding affinity to biotin-tagged PAK4 (unknown origin) assessed as dissociation constant by SPR analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50448771(CHEMBL3128042)
Affinity DataIC50: 4.80nMAssay Description:Inhibition of human recombinant PAK4 kinase domain assessed as phosphorylation of FRET peptide substrate at Ser/Thr20 by Zylite assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2016
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50505541(CHEMBL4465866)
Affinity DataKd:  5nMAssay Description:Binding affinity to recombinant human full-length N-terminal GST-tagged PAK4 expressed in baculovirus expression system using SGKtide as substrate in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101544(US8530652, 123 | US8530652, 71 | US8530494, 105)
Affinity DataKi:  5.20nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50043014(CHEMBL3355023)
Affinity DataIC50: 5.30nMAssay Description:Inhibition of human recombinant PAK4 kinase domain assessed as phosphorylation of FRET peptide substrate at Ser/Thr20 by Zylite assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2016
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50591962(CHEMBL5175418)
Affinity DataIC50: 5.90nMAssay Description:Inhibition of PAK4 (unknown origin) using S2 as substrate incubated for 60 mins in the presence of ATP by time-resolved HTRF assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50591962(CHEMBL5175418)
Affinity DataIC50: 5.90nMAssay Description:Inhibition of PAK4 (unknown origin) incubated for 60 mins by HTRF assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50591962(CHEMBL5175418)
Affinity DataIC50: 5.90nMAssay Description:Inhibition of PAK4 (unknown origin) using S2 substrate incubated for 60 mins in presence of ATP by HTRF assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50389111(CHEMBL2064555)
Affinity DataKi:  6nMAssay Description:Inhibition of PAK4 (unknown origin) assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50251179(CHEMBL4076708)
Affinity DataKd:  6nMAssay Description:Binding affinity to biotin-labeled human truncated PAK4 kinase domain by surface plasmon resonance assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2019
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50505542(CHEMBL4576489)
Affinity DataKd:  6nMAssay Description:Binding affinity to recombinant human full-length N-terminal GST-tagged PAK4 expressed in baculovirus expression system using SGKtide as substrate in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50251114(CHEMBL4076860)
Affinity DataKi:  6nMAssay Description:Inhibition of human PAK4 kinase domain using coumarin and fluorescein-labeled ser/thr20 peptide as substrate preincubated for 15 mins followed by ATP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2019
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50389111(CHEMBL2064555)
Affinity DataKi:  6nMAssay Description:Inhibition of PAK4More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
Displayed 1 to 50 (of 709 total ) | Next | Last >>
Jump to: